Sherry Crosby
Family · Pensacola, FLNPI 1215546288
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.3% of the total across 110 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 14.7% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $780, 4.2 times the $186 reported in 2021.
Across 110 payments — averaging $22.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$371
- E.r. Squibb & Sons, L.L.C.$249
- Eisai Inc.$229
- Incyte Corporation$226
- Progenics Pharmaceuticals, Inc.$136
- Myovant Sciences Inc.$131
- plus $1K from 27 others
What the payments were for
- Food & beverage$2,51099%
- Education$171%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 21 | $371 |
| E.r. Squibb & Sons, L.L.C. | 9 | $249 |
| Eisai Inc. | 9 | $229 |
| Incyte Corporation | 10 | $226 |
| Progenics Pharmaceuticals, Inc. | 2 | $136 |
| Myovant Sciences Inc. | 2 | $131 |
| Novocure Inc. | 1 | $113 |
| Bristol Myers Squibb | 5 | $106 |
| Regeneron Healthcare Solutions, Inc. | 3 | $106 |
| Genentech USA, Inc. | 5 | $89 |
| Springworks Therapeutics, Inc. | 5 | $86 |
| Johnson & Johnson | 5 | $84 |
| Sanofi | 4 | $77 |
| AVEO Pharmaceuticals, Inc. | 3 | $59 |
| Ipsen Biopharmaceuticals, Inc | 2 | $49 |
| AstraZeneca | 2 | $45 |
| Genmab U.S., Inc. | 3 | $44 |
| Pharmacosmos Therapeutics Inc. | 2 | $44 |
| Pfizer | 2 | $37 |
| Merck | 2 | $37 |
| Jazz Pharmaceuticals Inc. | 1 | $20 |
| Daiichi Sankyo Inc. | 1 | $19 |
| Beigene USA, Inc. | 1 | $19 |
| AbbVie | 1 | $18 |
| GSK | 1 | $17 |
| Octapharma USA, Inc. | 1 | $17 |
| Boehringer Ingelheim | 1 | $17 |
| Epizyme, Inc. | 1 | $16 |
| Mirati Therapeutics, Inc. | 1 | $14 |
| Array Biopharma Inc | 1 | $14 |
| Syndax Pharmaceuticals, Inc. | 1 | $14 |
| EMD Serono, Inc. | 1 | $12 |
| Amgen | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,527 in reported general payments places this provider in the 85th percentile of 14,618 family providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Anastrozole | 15 | $341 |
Paid to pharmacies, not to this prescriber.
Other family in Pensacola
- Brittany PerezPensacola$130K
- Mary AanestadPensacola$54K
- Raymond HalsteadPensacola$50K
- Lewis HarringtonTampa$954K
- Danielle PharesFt Lauderdale$713K
- Donna OrtizOrlando$417K
- Patrick SzarazMiami$327K
- Deena RodneyMaitland$323K
- Yamila MelendezMiami$212K
- Holly BoydLand O Lakes$200K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.